Price to Book Value Chart

View Price to Book Value for SNNAQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2017. Start Trial.
Date Value
September 18, 2026 0.00
September 17, 2026 0.00
September 16, 2026 0.00
September 15, 2026 0.00
September 14, 2026 0.00
September 11, 2026 0.00
September 10, 2026 0.00
September 09, 2026 0.00
September 08, 2026 0.00
September 04, 2026 0.00
September 03, 2026 0.0001
September 02, 2026 0.0001
September 01, 2026 0.0001
August 31, 2026 0.0001
August 28, 2026 0.0001
August 27, 2026 0.0001
August 26, 2026 0.0001
August 25, 2026 0.0001
August 24, 2026 0.0001
August 21, 2026 0.0001
August 20, 2026 0.0001
August 19, 2026 0.00
August 18, 2026 0.00
August 17, 2026 0.00
August 14, 2026 0.00
Date Value
August 13, 2026 0.00
August 12, 2026 0.00
August 11, 2026 0.00
August 10, 2026 0.00
August 07, 2026 0.00
August 06, 2026 0.00
August 05, 2026 0.00
August 04, 2026 0.00
August 03, 2026 0.00
July 31, 2026 0.00
July 30, 2026 0.00
July 29, 2026 0.00
July 28, 2026 0.00
July 27, 2026 0.00
July 24, 2026 0.00
July 23, 2026 0.00
July 22, 2026 0.00
July 21, 2026 0.00
July 20, 2026 0.00
July 17, 2026 0.00
July 16, 2026 0.00
July 15, 2026 0.00
July 14, 2026 0.00
July 13, 2026 0.00
July 10, 2026 0.00

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.929
Corcept Therapeutics, Inc. 16.86
Veru, Inc. 1.448
Johnson & Johnson 7.652
Eli Lilly & Co. 32.04

Price to Book Value Related Metrics

Price 0.0000